The Importance of the Clinical Analyst in Recognizing Promyelocytes in Acute Promyelocytic Leukemia for the Patient's Prognosis
Journal: International Journal of Advanced Engineering Research and Science (Vol.11, No. 12)Publication Date: 2024-12-07
Authors : Daniel Rodrigues Silva Gabriel Vieira Antunes Loiany Soares dos Santos Oliveira Arthur Quartezani Bruneli Lima Cleiton de Brito Pimenta Tarcísio Almeida Kretli Wanessa Soares Luiz Silva;
Page : 020-031
Keywords : Acute Promyelocytic Leukemia. APL. Disseminated Intravascular Coagulation. DIC. All-Trans Retinoic Acid. ATRA. Arsenic Trioxide. ATO.;
Abstract
APL (Acute Promyelocytic Leukemia) is a very aggressive type of myeloid leukemia characterized by the marked production of promyelocytes in the bone marrow and consequently an increase in peripheral circulation, triggering numerous hemorrhagic and thrombotic events, which makes this leukemia a medical emergency requiring immediate initiation of drug treatment.
Other Latest Articles
- Bilateral Agreement on Investment Fund: Problems and Prospects for Transformation into a «Marshall Plan» for the Recovery of Ukraine»
- A New Concept of Social Development Is Needed (Emotional View from a Distance)
- Economic Sustainability of Ukraine
- Voluntourism in Ukraine: Challenges and Opportunities
- Innovative Circular Solutions in Industrial Parks: Challenges of Energy and Resource Security
Last modified: 2025-07-02 13:12:38